Adams Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Adams Wealth Management's BMY Position: Q2 2026 in Review
Adams Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 27% in Q2 2026, buying an estimated $172K and bringing the position to 14,065 shares worth $810K. The position accounts for 0.16% of the portfolio, ranked #82.
Adams Wealth Management first reported a position in BMY in Q3 2020 and has held it in 6 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Adams Wealth Management held 14,065 shares of Bristol-Myers Squibb worth $810K as of Q2 2026.
- Adams Wealth Management bought 2,998 Bristol-Myers Squibb shares in Q2 2026, an estimated $172K.
- Bristol-Myers Squibb made up 0.16% of Adams Wealth Management's portfolio in Q2 2026, its #82 holding.
- Adams Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 6 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Adams Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.